Impact of CRISPR in cancer drug discovery

Jason Moffat,Alexis C. Komor,Lawrence Lum

DOI: https://doi.org/10.1126/science.adi6884

IF: 56.9

2024-10-25

Science

Abstract:Precision gene editing enables massively parallel identification of cancer-promoting genes

multidisciplinary sciences

What problem does this paper attempt to address?

The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy

Arun Pandian Chandrasekaran,Janardhan Keshav Karapurkar,Hee Yong Chung,Suresh Ramakrishna

DOI: https://doi.org/10.1002/biot.202100468

2022-02-20

Biotechnology Journal

Abstract:BACKGROUND: The recent emergence of gene editing using Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated system (Cas) tools and advances in genomics and proteomics has revolutionized drug discovery and personalized medicine.PURPOSE AND SCOPE: The CRISPR-Cas system has enabled gene and cell-based therapies, screening for novel drug targets, a new generation of disease models, elucidation of drug resistance mechanisms, and drug efficacy testing. Here, we summarized recent investigations and strategies involved in cancer-related drug discovery using the CRISPR-Cas system.CONCLUSION: CRISPR-Cas-mediated gene editing has shown great potential in the development of next generation drugs for treatment of Mendelian disorders and various cancer types. In this review, we focused on the impact of the CRISPR-Cas system in drug discovery and its application to biomarker identification and validation, high-end target genes, and breakthrough anticancer cell therapies. We also highlighted the role of CRISPR-Cas in precision disease modeling and functional drug screening.

biotechnology & applied microbiology,biochemical research methods
Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling

Mirunalini Ravichandran,Danilo Maddalo

DOI: https://doi.org/10.3389/fgene.2023.1273994

IF: 3.7

2023-10-17

Frontiers in Genetics

Abstract:The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) (CRISPR/Cas9) system is a powerful tool that enables precise and efficient gene manipulation. In a relatively short time, CRISPR has risen to become the preferred gene-editing system due to its high efficiency, simplicity, and programmability at low costs. Furthermore, in the recent years, the CRISPR toolkit has been rapidly expanding, and the emerging advancements have shown tremendous potential in uncovering molecular mechanisms and new therapeutic strategies for human diseases. In this review, we provide our perspectives on the recent advancements in CRISPR technology and its impact on precision medicine, ranging from target identification, disease modeling, and diagnostics. We also discuss the impact of novel approaches such as epigenome, base, and prime editing on preclinical cancer drug discovery.

genetics & heredity
CRISPR in cancer biology and therapy

Alyna Katti,Bianca J. Diaz,Christina M. Caragine,Neville E. Sanjana,Lukas E. Dow

DOI: https://doi.org/10.1038/s41568-022-00441-w

IF: 78.5

2022-02-22

Nature Reviews Cancer

Abstract:Over the past decade, CRISPR has become as much a verb as it is an acronym, transforming biomedical research and providing entirely new approaches for dissecting all facets of cell biology. In cancer research, CRISPR and related tools have offered a window into previously intractable problems in our understanding of cancer genetics, the noncoding genome and tumour heterogeneity, and provided new insights into therapeutic vulnerabilities. Here, we review the progress made in the development of CRISPR systems as a tool to study cancer, and the emerging adaptation of these technologies to improve diagnosis and treatment.

oncology
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research

Yue Yang,Jin Xu,Shuyu Ge,Liqin Lai

DOI: https://doi.org/10.3389/fmed.2021.649896

IF: 3.9

2021-03-03

Frontiers in Medicine

Abstract:Cancer is one of the most leading causes of mortalities worldwide. It is caused by the accumulation of genetic and epigenetic alterations in 2 types of genes: tumor suppressor genes (TSGs) and proto-oncogenes. In recent years, development of the clustered regularly interspaced short palindromic repeats (CRISPR) technology has revolutionized genome engineering for different cancer research ranging for research ranging from fundamental science to translational medicine and precise cancer treatment. The CRISPR/CRISPR associated proteins (CRISPR/Cas) are prokaryote-derived genome editing systems that have enabled researchers to detect, image, manipulate and annotate specific DNA and RNA sequences in various types of living cells. The CRISPR/Cas systems have significant contributions to discovery of proto-oncogenes and TSGs, tumor cell epigenome normalization, targeted delivery, identification of drug resistance mechanisms, development of high-throughput genetic screening, tumor models establishment, and cancer immunotherapy and gene therapy in clinics. Robust technical improvements in CRISPR/Cas systems have shown a considerable degree of efficacy, specificity, and flexibility to target the specific locus in the genome for the desired applications. Recent developments in CRISPRs technology offers a significant hope of medical cure against cancer and other deadly diseases. Despite significant improvements in this field, several technical challenges need to be addressed, such as off-target activity, insufficient indel or low homology-directed repair (HDR) efficiency, in vivo delivery of the Cas system components, and immune responses. This study aims to overview the recent technological advancements, preclinical and perspectives on clinical applications of CRISPR along with their advantages and limitations. Moreover, the potential applications of CRISPR/Cas in precise cancer tumor research, genetic, and other precise cancer treatments discussed.

medicine, general & internal
Harnessing the evolving CRISPR/Cas9 for precision oncology

Tianye Li,Shuiquan Li,Yue Kang,Jianwei Zhou,Ming Yi

DOI: https://doi.org/10.1186/s12967-024-05570-4

2024-08-08

Abstract:The Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 system, a groundbreaking innovation in genetic engineering, has revolutionized our approach to surmounting complex diseases, culminating in CASGEVY™ approved for sickle cell anemia. Derived from a microbial immune defense mechanism, CRISPR/Cas9, characterized as precision, maneuverability and universality in gene editing, has been harnessed as a versatile tool for precisely manipulating DNA in mammals. In the process of applying it to practice, the consecutive exploitation of novel orthologs and variants never ceases. It's conducive to understanding the essentialities of diseases, particularly cancer, which is crucial for diagnosis, prevention, and treatment. CRISPR/Cas9 is used not only to investigate tumorous genes functioning but also to model disparate cancers, providing valuable insights into tumor biology, resistance, and immune evasion. Upon cancer therapy, CRISPR/Cas9 is instrumental in developing individual and precise cancer therapies that can selectively activate or deactivate genes within tumor cells, aiming to cripple tumor growth and invasion and sensitize cancer cells to treatments. Furthermore, it facilitates the development of innovative treatments, enhancing the targeting efficiency of reprogrammed immune cells, exemplified by advancements in CAR-T regimen. Beyond therapy, it is a potent tool for screening susceptible genes, offering the possibility of intervening before the tumor initiative or progresses. However, despite its vast potential, the application of CRISPR/Cas9 in cancer research and therapy is accompanied by significant efficacy, efficiency, technical, and safety considerations. Escalating technology innovations are warranted to address these issues. The CRISPR/Cas9 system is revolutionizing cancer research and treatment, opening up new avenues for advancements in our understanding and management of cancers. The integration of this evolving technology into clinical practice promises a new era of precision oncology, with targeted, personalized, and potentially curative therapies for cancer patients.
CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

Mingming Qin,Chunhao Deng,Liewei Wen,Guoqun Luo,Ya Meng

DOI: https://doi.org/10.1186/s12967-024-05235-2

2024-05-30

Abstract:Target cancer therapy has been developed for clinical cancer treatment based on the discovery of CRISPR (clustered regularly interspaced short palindromic repeat) -Cas system. This forefront and cutting-edge scientific technique improves the cancer research into molecular level and is currently widely utilized in genetic investigation and clinical precision cancer therapy. In this review, we summarized the genetic modification by CRISPR/Cas and CRISPR screening system, discussed key components for successful CRISPR screening, including Cas enzymes, guide RNA (gRNA) libraries, target cells or organs. Furthermore, we focused on the application for CAR-T cell therapy, drug target, drug screening, or drug selection in both ex vivo and in vivo with CRISPR screening system. In addition, we elucidated the advantages and potential obstacles of CRISPR system in precision clinical medicine and described the prospects for future genetic therapy.In summary, we provide a comprehensive and practical perspective on the development of CRISPR/Cas and CRISPR screening system for the treatment of cancer defects, aiming to further improve the precision and accuracy for clinical treatment and individualized gene therapy.
CRISPR and Gene Editing: A Game-Changer in Drug Development

Abhishek Verma,Tarun Sharma,Ankit Awasthi

DOI: https://doi.org/10.2174/0113816128298080240328053845

IF: 3.31

2024-04-09

Current Pharmaceutical Design

Abstract:CRISPR and gene editing technologies have emerged as transformative tools in medicine, offering unprecedented precision in targeting genetic disorders and revolutionizing drug development. This review explores the multifaceted impact of CRISPR across various medical domains, from hereditary diseases to infectious diseases and cancer. The potential of CRISPR in personalized medicine, therapeutic innovation, and pandemic prevention is highlighted, along with its role in reshaping traditional drug...

pharmacology & pharmacy
CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment

Hui Xing,Ling-hua Meng

DOI: https://doi.org/10.1038/s41401-019-0322-9

IF: 7.169

2019-12-02

Acta Pharmacologica Sinica

Abstract:Cancer is a highly heterogeneous disease in term of molecular signature even though it is originated from the same tissue type. Cancer heterogeneity may occur during its development or treatment, which is the main cause resulting in drug resistance and recurrence. Precision medicine refers to matching the right medicine to the right patients based on their molecular signatures. Therefore, a thorough understanding of the mechanism of tumorigenesis and drug resistance is essential to precision medicine. CRISPR-cas9 system is a powerful tool for gene editing and CRISPR-based high-throughput screening has been widely applied especially in searching for tumor-driven or synergistic lethal genes aiming to overcome drug resistance. In this review, we describe the progress of CRISPR-cas9-based unbiased screening in precision medicine including identification of new drug targets, biomarkers and elucidation of mechanisms leading to drug resistance. The existing challenges as well as the future directions are also discussed.

pharmacology & pharmacy,chemistry, multidisciplinary
CRISPR-Cas9: from Genome Editing to Cancer Research

Si Chen,Heng Sun,Kai Miao,Chu-Xia Deng

DOI: https://doi.org/10.7150/ijbs.17421

2016-01-01

International Journal of Biological Sciences

Abstract:Cancer development is a multistep process triggered by innate and acquired mutations, which cause the functional abnormality and determine the initiation and progression of tumorigenesis. Gene editing is a widely used engineering tool for generating mutations that enhance tumorigenesis. The recent developed clustered regularly interspaced short palindromic repeats-CRISPR-associated 9 (CRISPR-Cas9) system renews the genome editing approach into a more convenient and efficient way. By rapidly introducing genetic modifications in cell lines, organs and animals, CRISPR-Cas9 system extends the gene editing into whole genome screening, both in loss-of-function and gain-of-function manners. Meanwhile, the system accelerates the establishment of animal cancer models, promoting in vivo studies for cancer research. Furthermore, CRISPR-Cas9 system is modified into diverse innovative tools for observing the dynamic bioprocesses in cancer studies, such as image tracing for targeted DNA, regulation of transcription activation or repression. Here, we view recent technical advances in the application of CRISPR-Cas9 system in cancer genetics, large-scale cancer driver gene hunting, animal cancer modeling and functional studies.
The Potential Revolution of Cancer Treatment with CRISPR Technology

Dimitrios Stefanoudakis,Nikhita Kathuria-Prakash,Alexander W. Sun,Melissa Abel,Claire E. Drolen,Camille Ashbaugh,Shiliang Zhang,Gavin Hui,Yeganeh A. Tabatabaei,Yuliya Zektser,Lidia P. Lopez,Allan Pantuck,Alexandra Drakaki

DOI: https://doi.org/10.3390/cancers15061813

2023-03-18

Cancers

Abstract:Immuno-oncology (IO) and targeted therapies, such as small molecule inhibitors, have changed the landscape of cancer treatment and prognosis; however, durable responses have been difficult to achieve due to tumor heterogeneity, development of drug resistance, and adverse effects that limit dosing and prolonged drug use. To improve upon the current medicinal armamentarium, there is an urgent need for new ways to understand, reverse, and treat carcinogenesis. Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) 9 is a powerful and efficient tool for genome editing that has shown significant promise for developing new therapeutics. While CRISPR/Cas9 has been successfully used for pre-clinical cancer research, its use in the clinical setting is still in an early stage of development. The purpose of this review is to describe the CRISPR technology and to provide an overview of its current applications and future potential as cancer therapies.

oncology
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine

Aditya Kumar Sharma,Anil K. Giri

DOI: https://doi.org/10.3389/fgene.2024.1309175

IF: 3.7

2024-04-26

Frontiers in Genetics

Abstract:The discovery of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) technology has revolutionized field of cancer treatment. This review explores usage of CRISPR/Cas9 for editing and investigating genes involved in human carcinogenesis. It provides insights into the development of CRISPR as a genetic tool. Also, it explores recent developments and tools available in designing CRISPR/Cas9 systems for targeting oncogenic genes for cancer treatment. Further, we delve into an overview of cancer biology, highlighting key genetic alterations and signaling pathways whose deletion prevents malignancies. This fundamental knowledge enables a deeper understanding of how CRISPR/Cas9 can be tailored to address specific genetic aberrations and offer personalized therapeutic approaches. In this review, we showcase studies and preclinical trials that show the utility of CRISPR/Cas9 in disrupting oncogenic targets, modulating tumor microenvironment and increasing the efficiency of available anti treatments. It also provides insight into the use of CRISPR high throughput screens for cancer biomarker identifications and CRISPR based screening for drug discovery. In conclusion, this review offers an overview of exciting developments in engineering CRISPR/Cas9 therapeutics for cancer treatment and highlights the transformative potential of CRISPR for innovation and effective cancer treatments.

genetics & heredity
CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer

Pratik Talukder,Sounak Chanda,Biswadeep Chaudhuri,Sonjoy Roy Choudhury,Debanjan Saha,Sudipta Dash,Abhineet Banerjee,Bhaskarjyaa Chatterjee

DOI: https://doi.org/10.1007/s12010-023-04708-2

2023-09-22

Applied Biochemistry and Biotechnology

Abstract:The development and emergence of clustered regularly interspaced short palindromic repeats (CRISPR) as a genome-editing technology have created a plethora of opportunities in genetic engineering. The ability of sequence-specific addition or removal of DNA in an efficient and cost-effective manner has revolutionized modern research in the field of life science and healthcare. CRISPR is widely used as a genome engineering tool in clinical studies for observing gene expression and metabolic pathway regulations in detail. Even in the case of transgenic research and personalized gene manipulation studies, CRISPR-based technology is used extensively. To understand and even to correct the underlying genetic problem is of cancer, CRISPR-based technology can be used. Various kinds of work is going on throughout the world which are attempting to target different genes in order to discover novel and effective methodologies for the treatment of cancer. In this review, we provide a brief overview on the application of CRISPR gene editing technology in cancer treatment focusing on the key aspects of cancer screening, modelling and therapy techniques.

biotechnology & applied microbiology,biochemistry & molecular biology
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)

Stella Baliou,Maria Adamaki,Anthony M Kyriakopoulos,Demetrios A Spandidos,Mihalis Panayiotidis,Ioannis Christodoulou,Vassilis Zoumpourlis

DOI: https://doi.org/10.3892/ijo.2018.4434

Abstract:One of the fundamental discoveries in the field of biology is the ability to modulate the genome and to monitor the functional outputs derived from genomic alterations. In order to unravel new therapeutic options, scientists had initially focused on inducing genetic alterations in primary cells, in established cancer cell lines and mouse models using either RNA interference or cDNA overexpression or various programmable nucleases [zinc finger nucleases (ZNF), transcription activator-like effector nucleases (TALEN)]. Even though a huge volume of data was produced, its use was neither cheap nor accurate. Therefore, the clustered regularly interspaced short palindromic repeats (CRISPR) system was evidenced to be the next step in genome engineering tools. CRISPR-associated protein 9 (Cas9)-mediated genetic perturbation is simple, precise and highly efficient, empowering researchers to apply this method to immortalized cancerous cell lines, primary cells derived from mouse and human origins, xenografts, induced pluripotent stem cells, organoid cultures, as well as the generation of genetically engineered animal models. In this review, we assess the development of the CRISPR system and its therapeutic applications to a wide range of complex diseases (particularly distinct tumors), aiming at personalized therapy. Special emphasis is given to organoids and CRISPR screens in the design of innovative therapeutic approaches. Overall, the CRISPR system is regarded as an eminent genome engineering tool in therapeutics. We envision a new era in cancer biology during which the CRISPR-based genome engineering toolbox will serve as the fundamental conduit between the bench and the bedside; nonetheless, certain obstacles need to be addressed, such as the eradication of side-effects, maximization of efficiency, the assurance of delivery and the elimination of immunogenicity.
Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

Xiangying Deng

DOI: https://doi.org/10.54254/2753-8818/27/20240708

2023-12-20

Abstract:The background of CRISPRs development lies in the long-standing need for precise gene editing tools, which culminated in the revolutionary CRISPR-Cas9 system in 2012. This technology has had profound impacts on biology, medicine, and biotechnology, offering versatile applications in gene therapy, agriculture, and research across eukaryotes, prokaryotes, and archaea. In the context of cancer research, CRISPR has shown promise in understanding cancer biology, identifying therapeutic targets, enhancing immunotherapy, and potentially enabling early cancer diagnosis and personalized treatment. However, challenges remain, including the need to enhance precision, address ethical concerns, and conduct rigorous clinical trials. This article examines CRISPRs advancements in cancer treatment and concludes that, when compared to other gene editing methods, it offers benefits like robust targeting, easy operation, and efficient editing. Based on these benefits, the application prospect of CRISPR in enhancing personalized medicine, drug development, and cancer treatment is also discussed in this article. This article highlights the need for addressing precision and safety issues and the importance of interdisciplinary collaboration and stringent regulation in realizing the full potential of CRISPR in cancer treatment. In conclusion, CRISPR offers promising avenues for improving cancer treatment by enabling precise gene editing and personalized therapies. Despite the challenges, continuous advancements in technology and research, along with stricter regulation, will ensure the safe and effective use of CRISPR in cancer, providing hope for cancer patients and shaping the future of oncology research.
CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

Shuai Ding,Jinfeng Liu,Xin Han,Mengfan Tang

DOI: https://doi.org/10.3390/ijms242216325

2023-11-15

Abstract:The Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system, an RNA-based adaptive immune system found in bacteria and archaea, has catalyzed the development and application of a new generation of gene editing tools. Numerous studies have shown that this system can precisely target a wide range of human genes, including those associated with diseases such as cancer. In cancer research, the intricate genetic mutations in tumors have promoted extensive utilization of the CRISPR/Cas9 system due to its efficient and accurate gene editing capabilities. This includes improvements in Chimeric Antigen Receptor (CAR)-T-cell therapy, the establishment of tumor models, and gene and drug target screening. Such progress has propelled the investigation of cancer molecular mechanisms and the advancement of precision medicine. However, the therapeutic potential of genome editing remains underexplored, and lingering challenges could elevate the risk of additional genetic mutations. Here, we elucidate the fundamental principles of CRISPR/Cas9 gene editing and its practical applications in tumor research. We also briefly discuss the primary challenges faced by CRISPR technology and existing solutions, intending to enhance the efficacy of this gene editing therapy and shed light on the underlying mechanisms of tumors.
Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment

Chunyang Jiang,Lingxiang Meng,Bingjun Yang,Xin Luo

DOI: https://doi.org/10.1111/cge.13589

2019-07-10

Clinical Genetics

Abstract:<p>In recent years, gene editing, especially that using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9, has made great progress in the field of gene function. Rapid development of gene editing techniques has contributed to their significance in the field of medicine. Because the CRISPR/Cas9 gene editing tool is not only powerful but also has features such as strong specificity and high efficiency, it can accurately and rapidly screen the whole genome, facilitating the administration of gene therapy for specific diseases. In the field of tumor research, CRISPR/Cas9 can be used to edit genomes to explore the mechanisms of tumor occurrence, development, and metastasis. In these years, this system has been increasingly applied in tumor treatment research. CRISPR/Cas9 can be used to treat tumors by repairing mutations or knocking out specific genes. To date, numerous preliminary studies have been conducted on tumor treatment in related fields. CRISPR/Cas9 holds great promise for gene‐level tumor treatment. Personalized and targeted therapy based on CRISPR/Cas9 will possibly shape the development of tumor therapy in the future. In this study, we review the findings of CRISPR/Cas9 for tumor treatment research to provide references for related future studies on the pathogenesis and clinical treatment of tumors.</p><p>This article is protected by copyright. All rights reserved.</p>

genetics & heredity
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

Si-Wei Wang,Chao Gao,Yi-Min Zheng,Li Yi,Jia-Cheng Lu,Xiao-Yong Huang,Jia-Bin Cai,Peng-Fei Zhang,Yue-Hong Cui,Ai-Wu Ke

DOI: https://doi.org/10.1186/s12943-022-01518-8

IF: 37.3

2022-02-21

Molecular Cancer

Abstract:Abstract Clustered regularly interspaced short palindromic repeats (CRISPR) system provides adaptive immunity against plasmids and phages in prokaryotes. This system inspires the development of a powerful genome engineering tool, the CRISPR/CRISPR-associated nuclease 9 (CRISPR/Cas9) genome editing system. Due to its high efficiency and precision, the CRISPR/Cas9 technique has been employed to explore the functions of cancer-related genes, establish tumor-bearing animal models and probe drug targets, vastly increasing our understanding of cancer genomics. Here, we review current status of CRISPR/Cas9 gene editing technology in oncological research. We first explain the basic principles of CRISPR/Cas9 gene editing and introduce several new CRISPR-based gene editing modes. We next detail the rapid progress of CRISPR screening in revealing tumorigenesis, metastasis, and drug resistance mechanisms. In addition, we introduce CRISPR/Cas9 system delivery vectors and finally demonstrate the potential of CRISPR/Cas9 engineering to enhance the effect of adoptive T cell therapy (ACT) and reduce adverse reactions.

oncology,biochemistry & molecular biology
Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed

Karim Kanbar,Roy El Darzi,Diana E Jaalouk

DOI: https://doi.org/10.3389/fgene.2024.1434002

2024-07-31

Abstract:Cancer continues to present a substantial global health challenge, with its incidence and mortality rates persistently reflecting its significant impact. The emergence of precision oncology has provided a breakthrough in targeting oncogenic drivers previously deemed "undruggable" by conventional therapeutics and by limiting off-target cytotoxicity. Two groundbreaking technologies that have revolutionized the field of precision oncology are primarily CRISPR-Cas9 gene editing and more recently PROTAC (PROteolysis TArgeting Chimeras) targeted protein degradation technology. CRISPR-Cas9, in particular, has gained widespread recognition and acclaim due to its remarkable ability to modify DNA sequences precisely. Rather than editing the genetic code, PROTACs harness the ubiquitin proteasome degradation machinery to degrade proteins of interest selectively. Even though CRISPR-Cas9 and PROTAC technologies operate on different principles, they share a common goal of advancing precision oncology whereby both approaches have demonstrated remarkable potential in preclinical and promising data in clinical trials. CRISPR-Cas9 has demonstrated its clinical potential in this field due to its ability to modify genes directly and indirectly in a precise, efficient, reversible, adaptable, and tissue-specific manner, and its potential as a diagnostic tool. On the other hand, the ability to administer in low doses orally, broad targeting, tissue specificity, and controllability have reinforced the clinical potential of PROTAC. Thus, in the field of precision oncology, gene editing using CRISPR technology has revolutionized targeted interventions, while the emergence of PROTACs has further expanded the therapeutic landscape by enabling selective protein degradation. Rather than viewing them as mutually exclusive or competing methods in the field of precision oncology, their use is context-dependent (i.e., based on the molecular mechanisms of the disease) and they potentially could be used synergistically complementing the strengths of CRISPR and vice versa. Herein, we review the current status of CRISPR and PROTAC designs and their implications in the field of precision oncology in terms of clinical potential, clinical trial data, limitations, and compare their implications in precision clinical oncology.
Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics

Ajaz A. Bhat,Sabah Nisar,Soumi Mukherjee,Nirmalya Saha,Nageswari Yarravarapu,Saife N. Lone,Tariq Masoodi,Ravi Chauhan,Selma Maacha,Puneet Bagga,Punita Dhawan,Ammira Al-Shabeeb Akil,Wael El-Rifai,Shahab Uddin,Ravinder Reddy,Mayank Singh,Muzafar A. Macha,Mohammad Haris

DOI: https://doi.org/10.1186/s12967-022-03765-1

IF: 8.44

2022-11-19

Journal of Translational Medicine

Abstract:Gene editing has great potential in treating diseases caused by well-characterized molecular alterations. The introduction of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)–based gene-editing tools has substantially improved the precision and efficiency of gene editing. The CRISPR/Cas9 system offers several advantages over the existing gene-editing approaches, such as its ability to target practically any genomic sequence, enabling the rapid development and deployment of novel CRISPR-mediated knock-out/knock-in methods. CRISPR/Cas9 has been widely used to develop cancer models, validate essential genes as druggable targets, study drug-resistance mechanisms, explore gene non-coding areas, and develop biomarkers. CRISPR gene editing can create more-effective chimeric antigen receptor (CAR)-T cells that are durable, cost-effective, and more readily available. However, further research is needed to define the CRISPR/Cas9 system's pros and cons, establish best practices, and determine social and ethical implications. This review summarizes recent CRISPR/Cas9 developments, particularly in cancer research and immunotherapy, and the potential of CRISPR/Cas9-based screening in developing cancer precision medicine and engineering models for targeted cancer therapy, highlighting the existing challenges and future directions. Lastly, we highlight the role of artificial intelligence in refining the CRISPR system's on-target and off-target effects, a critical factor for the broader application in cancer therapeutics.

medicine, research & experimental
A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment

Xianguang Yang,Baohong Zhang

DOI: https://doi.org/10.1007/s10142-023-01117-w

2023-05-27

Abstract:Cancer is one of the leading causes of death worldwide and it has the trend of increase incidence. However, in the past decades, as quickly developed new technologies and modified old techniques for cancer screening, diagnosis, and treatment, the cancer-caused mortality rates dropped quickly, and the survival times of cancer patients are enhanced. However, the current death rate is still about 50% and the survival patients always suffer from the side effect of current cancer treatments. Recently developed Nobel Prize–winning CRISPR/Cas technology provides new hope on cancer screening, early diagnosis, and clinic treatment as well as new drug development. Currently, four major CRISPR/Cas9-derived genome editors, CRISPR/Cas9 nucleotide sequence editor, CRISPR/Cas base editor (BE), CRISPR prime editor (PE), and CRISPR interference (CRISPRi) (including both CRISPRa and CRISPRr), were well developed and used to various research and applications, including cancer biology study and cancer screening, diagnosis, and treatment. Additionally, CRISPR/Cas12 and CRISPR/Cas13 genome editors were also widely used in cancer-related basic and applied research as well as treatment. Cancer-associated SNPs and genetic mutations as well as both oncogenes and tumor suppressor genes are perfect targets for CRISPR/Cas-based gene therapy for cancer treatment. CRISPR/Cas is also employed to modify and generate new Chimeric antigen receptor (CAR) T-cells for improving its safety, efficiency, and longer-time last for treating various cancers. Currently, there are many clinic trails of CRISPR-based gene therapy for cancer treatments. Although all CRISPR/Cas-derived genome and epigenome tools are promising methods for cancer biology study and treatment, the efficiency and long term-safety are still the major concerns for CRISPR-based gene therapy. Developing new CRISPR/Cas delivery methods and reducing the potential side effects, including off-target impacts, will enhance CRISPR/Cas application in cancer-related research, diagnosis, and therapeutical treatment.

genetics & heredity

Impact of CRISPR in cancer drug discovery

The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy

Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling

CRISPR in cancer biology and therapy

CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research

Harnessing the evolving CRISPR/Cas9 for precision oncology

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

CRISPR and Gene Editing: A Game-Changer in Drug Development

CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment

CRISPR-Cas9: from Genome Editing to Cancer Research

The Potential Revolution of Cancer Treatment with CRISPR Technology

Engineering CRISPR/Cas9 therapeutics for cancer precision medicine

CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer

CRISPR therapeutic tools for complex genetic disorders and cancer (Review)

Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed

Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment